Search Results - "Petrof, G."

Refine Results
  1. 1

    Fibroblast cell therapy enhances initial healing in recessive dystrophic epidermolysis bullosa wounds: results of a randomized, vehicle-controlled trial by Petrof, G., Martinez-Queipo, M., Mellerio, J.E., Kemp, P., McGrath, J.A.

    Published in British journal of dermatology (1951) (01-11-2013)
    “…Summary Background Fibroblast cell therapy can modify disease biology in recessive dystrophic epidermolysis bullosa (RDEB) although whether it improves wound…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    To what extent do disease severity and illness perceptions explain depression, anxiety and quality of life in hidradenitis suppurativa? by Pavon Blanco, A., Turner, M.A., Petrof, G., Weinman, J.

    Published in British journal of dermatology (1951) (01-02-2019)
    “…Summary Background Hidradenitis suppurativa (HS) can have significant psychological consequences and affect quality of life (QoL). This has been associated…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Infantile haemangioma presenting in combination with a cerebriform naevus sebaceous on the scalp by Chottianchaiwat, S., Martinez, A. E., Solman, L., Petrof, G.

    Published in Clinical and experimental dermatology (01-01-2022)
    “…Click https://wileyhealthlearning.com/#/online-courses/a54fac75-89f4-4bf5-80a4-19e31765a7a4 for the corresponding questions to this CME article…”
    Get full text
    Journal Article
  7. 7

    Illness perceptions and health outcomes in HS by Pavon Blanco, A., Turner, M.A., Petrof, G., Weinman, J.

    Published in British journal of dermatology (1951) (01-02-2019)
    “…Summary Hidradenitis Suppurativa (HS) is a chronic skin condition that affects between 1 and 2% of the European population. It is caused by inflammation of the…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Desmosomal genodermatoses by Petrof, G., Mellerio, J.E., McGrath, J.A.

    Published in British journal of dermatology (1951) (01-01-2012)
    “…Summary Desmosomes are intercellular junctions that contribute to cell–cell adhesion, signalling, development and differentiation in various tissues, including…”
    Get full text
    Journal Article
  10. 10

    Otological complications in inversa type recessive dystrophic epidermolysis bullosa by Robertson, S. J., Prodinger, C., Liu, L., Skilbeck, C., Petrof, G., Martinez, A. E., Mellerio, J. E., Greenblatt, D. T.

    Published in Clinical and experimental dermatology (01-04-2022)
    “…Summary Background The rare inversa subtype of recessive dystrophic epidermolysis bullosa (RDEB‐I) is characterized by predominant intertriginous skin…”
    Get full text
    Journal Article
  11. 11

    Prevalence and treatment of vitamin K deficiency in paediatric patients with recessive dystrophic epidermolysis bullosa‐severe subtype by Yerlett, N., Petrof, G., Holsgrove, K., Martinez, A.

    Published in Skin health and disease (01-06-2021)
    “…Introduction Patients with recessive dystrophic epidermolysis bullosa‐severe subtype (RDEB‐S) are at risk of vitamin K deficiency, potentially causing abnormal…”
    Get full text
    Journal Article
  12. 12
  13. 13

    A systematic review of the literature on the treatment of pityriasis rubra pilaris type 1 with TNF-antagonists by Petrof, G., Almaani, N., Archer, C.B., Griffiths, W.A.D., Smith, C.H.

    “…Background  Adult pityriasis rubra pilaris (PRP) type 1 is a rare chronic papulosquamous disorder with clinical and histological parallels with psoriasis…”
    Get full text
    Journal Article
  14. 14

    Clinical features and WNT10A mutations in seven unrelated cases of Schöpf-Schulz-Passarge syndrome by Tziotzios, C., Petrof, G., Liu, L., Verma, A., Wedgeworth, E.K., Mellerio, J.E., McGrath, J.A.

    Published in British journal of dermatology (1951) (01-11-2014)
    “…Summary Background Schöpf‐Schulz‐Passarge syndrome (SSPS) is an autosomal recessive form of ectodermal dysplasia resulting from mutations in WNT10A. Objectives…”
    Get full text
    Journal Article
  15. 15

    Optimal Management Of Chronic Wounds In Paediatric Junctional Epidermolysis Bullosa Patients by McDonald, CR, Plevey, K, Petrof, G, Martinez, AE

    Published in Chronic wound care management and research (01-10-2019)
    “…Epidermolysis bullosa (EB) is a group of rare genetic mucocutaneous fragility disorders. Patients with EB can experience blister formation following minor skin…”
    Get full text
    Journal Article
  16. 16

    化脓性汗腺炎患者的疾病感受和健康结局 by Pavon Blanco, A., Turner, M.A., Petrof, G., Weinman, J.

    Published in British journal of dermatology (1951) (01-02-2019)
    “…Summary 化脓性汗腺炎 (HS) 是一种慢性皮肤病,1% 到 2% 的欧洲人口受到累及。该病由毛囊和汗腺发炎所引起,可导致腋窝内、腹股沟、生殖器和乳房下方的皮肤下面发生有疼痛感并散发难闻气味的肿胀。HS 与抑郁、焦虑和生活质量 (QoL)…”
    Get full text
    Journal Article
  17. 17

    Infliximab for the treatment of psoriasis in the U.K.: 9 years' experience of infusion reactions at a single centre by Wee, J.S., Petrof, G., Jackson, K., Barker, J.N.W.N., Smith, C.H.

    Published in British journal of dermatology (1951) (01-08-2012)
    “…Summary Background  Infliximab is an antitumour necrosis factor‐α chimeric monoclonal antibody that is an established treatment for severe chronic plaque…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018 by Lewis, F.M., Tatnall, F.M., Velangi, S.S., Bunker, C.B., Kumar, A., Brackenbury, F., Mohd Mustapa, M.F., Exton, L.S.

    Published in British journal of dermatology (1951) (01-04-2018)
    “…Linked Comment: Akel and Fuller. Br J Dermatol 2018; 178:823–824. Plain language summary available online…”
    Get full text
    Journal Article